Guru World

Pounding the Table for AbbVie

The company’s product portfolio outside of Humira is very strong. It also gave investors another 10% dividend increaseRelated Stocks: ABBV, BMY, LLY, MRK, NVS, PFE, SNY,

Read more: gurufocus.com

Tags

Related Articles

Back to top button
Close
Close